ESC 365 - Patients with (pre-)diabetes and HFpEF : how do we treat phenogroups?

EAPC Premium Access

Patients with (pre-)diabetes and HFpEF : how do we treat phenogroups?

Session: Pre-diabetes and metabolic syndrome: what are they and what do they mean for cardiovascular risk

Topic: Diabetes and the Heart

Speaker: Doctor A. Alogna (Berlin, DE)

Event: ESC Preventive Cardiology 2023

Congress Presentation

Add to my library

About the speaker

Doctor Alessio Alogna

German Heart Centre Berlin, Berlin (Germany)

3 presentations

0 follower

4 more presentations in this session

Prediabetes – why is it relevant for cardiovascular and neurological disease risk?

Speaker: Professor C. Stehouwer (Maastricht, NL)

Pre-diabetes: when and how to act to delay CV risk progression

Speaker: Unknown S. Kabisch (Berlin, DE)

Is bempedoic acid better than statins to avoid new-onset diabetes?

Speaker: Professor M. Banach (Lodz, PL)

Discussion – Pre-diabetes and metabolic syndrome: what are they and what do they mean for cardiovascular risk

Access the full session

Pre-diabetes and metabolic syndrome: what are they and what do they mean for cardiovascular risk

Speakers: Doctor A. Alogna, Professor C. Stehouwer, Unknown S. Kabisch, Professor M. Banach

About the event

ESC Preventive Cardiology 2023

13 April - 15 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources